An LSC epigenetic signature is largely mutation independent and implicates the HOXA cluster in AML pathogenesis

Namyoung Jung, Bo Dai, Andrew J. Gentles, Ravindra Majeti, Andrew P Feinberg

Research output: Contribution to journalArticle

Abstract

Acute myeloid leukaemia (AML) is characterized by subpopulations of leukaemia stem cells (LSCs) that are defined by their ability to engraft in immunodeficient mice. Here we show an LSC DNA methylation signature, derived from xenografts and integration with gene expression that is comprised of 71 genes and identifies a key role for the HOXA cluster. Most of the genes are epigenetically regulated independently of underlying mutations, although several are downstream targets of epigenetic modifier genes mutated in AML. The LSC epigenetic signature is associated with poor prognosis independent of known risk factors such as age and cytogenetics. Analysis of early haematopoietic progenitors from normal individuals reveals two distinct clusters of AML LSC resembling either lymphoid-primed multipotent progenitors or granulocyte/macrophage progenitors. These results provide evidence for DNA methylation variation between AML LSCs and their blast progeny, and identify epigenetically distinct subgroups of AML likely reflecting the cell of origin.

Original languageEnglish (US)
Article number8489
JournalNature Communications
Volume6
DOIs
StatePublished - Oct 7 2015

Fingerprint

pathogenesis
leukemias
stem cells
mutations
Stem cells
Acute Myeloid Leukemia
Epigenomics
Leukemia
Stem Cells
signatures
Mutation
DNA Methylation
Genes
genes
Modifier Genes
Granulocyte-Macrophage Progenitor Cells
methylation
Macrophages
Heterografts
Gene expression

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Chemistry(all)
  • Physics and Astronomy(all)

Cite this

An LSC epigenetic signature is largely mutation independent and implicates the HOXA cluster in AML pathogenesis. / Jung, Namyoung; Dai, Bo; Gentles, Andrew J.; Majeti, Ravindra; Feinberg, Andrew P.

In: Nature Communications, Vol. 6, 8489, 07.10.2015.

Research output: Contribution to journalArticle

@article{a75136658469408bba92dc52dedb1d71,
title = "An LSC epigenetic signature is largely mutation independent and implicates the HOXA cluster in AML pathogenesis",
abstract = "Acute myeloid leukaemia (AML) is characterized by subpopulations of leukaemia stem cells (LSCs) that are defined by their ability to engraft in immunodeficient mice. Here we show an LSC DNA methylation signature, derived from xenografts and integration with gene expression that is comprised of 71 genes and identifies a key role for the HOXA cluster. Most of the genes are epigenetically regulated independently of underlying mutations, although several are downstream targets of epigenetic modifier genes mutated in AML. The LSC epigenetic signature is associated with poor prognosis independent of known risk factors such as age and cytogenetics. Analysis of early haematopoietic progenitors from normal individuals reveals two distinct clusters of AML LSC resembling either lymphoid-primed multipotent progenitors or granulocyte/macrophage progenitors. These results provide evidence for DNA methylation variation between AML LSCs and their blast progeny, and identify epigenetically distinct subgroups of AML likely reflecting the cell of origin.",
author = "Namyoung Jung and Bo Dai and Gentles, {Andrew J.} and Ravindra Majeti and Feinberg, {Andrew P}",
year = "2015",
month = "10",
day = "7",
doi = "10.1038/ncomms9489",
language = "English (US)",
volume = "6",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - An LSC epigenetic signature is largely mutation independent and implicates the HOXA cluster in AML pathogenesis

AU - Jung, Namyoung

AU - Dai, Bo

AU - Gentles, Andrew J.

AU - Majeti, Ravindra

AU - Feinberg, Andrew P

PY - 2015/10/7

Y1 - 2015/10/7

N2 - Acute myeloid leukaemia (AML) is characterized by subpopulations of leukaemia stem cells (LSCs) that are defined by their ability to engraft in immunodeficient mice. Here we show an LSC DNA methylation signature, derived from xenografts and integration with gene expression that is comprised of 71 genes and identifies a key role for the HOXA cluster. Most of the genes are epigenetically regulated independently of underlying mutations, although several are downstream targets of epigenetic modifier genes mutated in AML. The LSC epigenetic signature is associated with poor prognosis independent of known risk factors such as age and cytogenetics. Analysis of early haematopoietic progenitors from normal individuals reveals two distinct clusters of AML LSC resembling either lymphoid-primed multipotent progenitors or granulocyte/macrophage progenitors. These results provide evidence for DNA methylation variation between AML LSCs and their blast progeny, and identify epigenetically distinct subgroups of AML likely reflecting the cell of origin.

AB - Acute myeloid leukaemia (AML) is characterized by subpopulations of leukaemia stem cells (LSCs) that are defined by their ability to engraft in immunodeficient mice. Here we show an LSC DNA methylation signature, derived from xenografts and integration with gene expression that is comprised of 71 genes and identifies a key role for the HOXA cluster. Most of the genes are epigenetically regulated independently of underlying mutations, although several are downstream targets of epigenetic modifier genes mutated in AML. The LSC epigenetic signature is associated with poor prognosis independent of known risk factors such as age and cytogenetics. Analysis of early haematopoietic progenitors from normal individuals reveals two distinct clusters of AML LSC resembling either lymphoid-primed multipotent progenitors or granulocyte/macrophage progenitors. These results provide evidence for DNA methylation variation between AML LSCs and their blast progeny, and identify epigenetically distinct subgroups of AML likely reflecting the cell of origin.

UR - http://www.scopus.com/inward/record.url?scp=84943616457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943616457&partnerID=8YFLogxK

U2 - 10.1038/ncomms9489

DO - 10.1038/ncomms9489

M3 - Article

C2 - 26444494

AN - SCOPUS:84943616457

VL - 6

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

M1 - 8489

ER -